Results 91 to 100 of about 879,847 (177)

Trichomonas vaginalis: paradigm of a successful sexually transmitted organism

open access: yes, 2005
Trichomonas vaginalis (TV) is one of the most successful protozoan pathogens and one of the most common sexually transmitted organism in females, yet it is also one of the most poorly investigated.
Greenwell, P., Rughooputh, S.
core  

Trichomonas Vaginalis-A Clinical Image

open access: yes, 2017
A 32-year-old G4P301LC3 woman presents to the office for a visit, with a 6-day history of vaginal discharge with an unpleasant odor. On speculum examination, the discharge was green in color and frothy in appearance.
Astrit M Gashi*, Gashi AM
core   +1 more source

Antiviral Nucleoside Analogs as Potential Chemotherapy for Trichomonas vaginalis Infections

open access: yes, 2008
Trichomonas vagina/is is an anaerobic parasitic protozoan. Trichomonas is a sexually transmitted disease which is found mostly in females. It has the highest rate of infection of humans in industrialized countries.
Le, Van   +2 more
core  

Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma

open access: yes, 2017
Trichomonas vaginalis is a protozoan with an extracellular obligatory parasitic lifestyle exclusively adapted to the human urogenital tract and responsible for nearly a quarter billion sexually transmitted infections worldwide each year.
Raina Fichorova   +7 more
core   +1 more source

The Association Between Oral Contraceptives, Depot-Medroxyprogesterone Acetate, and Trichomoniasis [PDF]

open access: yes, 2009
Hormonal contraception use by women may increase the risk of acquiring certain sexually transmitted infections. We explored the effect of hormonal contraceptive use, specifically oral contraception (OC), and depot-medroxyprogesterone acetate (DMPA) on ...
MacDonald, Pia D. M.   +13 more
core   +1 more source

In Vitro Anti-Trichomonas Activity of Nucleoside Transition State Analogs

open access: yes, 2015
Trichomonas vaginalis is one of the most common sexually transmitted infections (STI) diagnosed each year in the United States. Unfortunately, Trichomonas has become increasingly resistant Metronidazole (MTZ), the primary FDA approved drug used for its ...
Carfi, Ryan   +2 more
core  

Impact of the COVID-19 pandemic on the percentage of positive urine tests for Trichomonas vaginalis

open access: yesHU Revista
Trichomoniasis is the most common non-viral sexually transmitted infection (STI) in the world. It is caused by the protozoan Trichomonas vaginalis, and most infections are asymptomatic – making difficult the diagnosis and allowing the parasite to spread.
Lauren Hubert Jaeger   +6 more
doaj   +1 more source

Trichomoniasis. The phenomenon of presence of Trichomonas Tenax s in the human genitourinary system [PDF]

open access: yes, 2014
At research of secretions of the genitourinary system of man by an optical microscopy and Polymerase chain reaction simultaneously in a number of cases it was found out the presence of the simplest, which are not Trichomonas vaginalis.
Fedorych, Р. V.   +3 more
core  

The epidemiology of sexually transmitted infections in the United Kingdom: impact of behaviour, services and interventions [PDF]

open access: yes, 2015
Sexually transmitted infections (STIs) are a major public health concern. The United Kingdom (UK) has some of the most advanced STI surveillance systems globally.
Hughes, Gwenda, Field, Nigel
core  

Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears

open access: yes, 2012
WOS: 000308510700015PubMed ID: 23157037Objective: The aim of this study was to determine the role of Papanicolaou (pap) smears in the diagnosis of lower genital tract infections.
Dunder, I.   +5 more
core  

Home - About - Disclaimer - Privacy